|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03378 HANXBIO-B
Nominal 
28.720 +1.080 (+3.907%) | 2025/12 - Final RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (104,894) | (51,994) |
| Net Cash from / (used in) Investing Activities | -- | 96,620 | 93,956 |
| Net Cash from / (used in) Financing Activities | -- | 6,486 | 90,220 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (1,788) | 132,182 |
| Cash & Cash Equivalents at beginning of period | -- | 162,000 | 29,789 |
| Effect of Foreign Exchange Rate Changes | -- | 1,002 | 29 |
| Others | -- | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 161,214 | 162,000 |
| Remarks: | Real time quote last updated: 27/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -131,007 |
| %Change | 13.103% |
| EPS / (LPS) | RMB -1.110 |
| NBV Per Share (¥) | RMB -- |